Penny Beuning from Northeastern University's college of science and colleagues are studying UmuD that regulates mutagenesis and may provide important clues about how to stop the process that eventually results in antimicrobial resistance.
Using the bacterium E coli as a model, she has learned that UmuD interacts with the machinery that replicates DNA, and, when altered, may provide the switch that triggers mutation.
UmuD exists in two forms, a full length version when first expressed, and later, if DNA is damaged, a much shorter form. It is this shorter version that allows bacteria to mutate.
In cells where only the full-length version of the protein is present, the bacteria cannot mutate.
"But when it forms its shorter self, the cells are mutable," she said.
The fact that UmuD is not present outside bacteria makes it a viable antibiotic target.
"The hope would be to find something that targets UmuD together with an existing antibiotic to prevent bacteria from mutating and developing a resistance to that particular drug," Beuning said.
Beuning specifically is looking at the cleavage process of UmuD using gel electrophoresis, which separates proteins according to size.
"UmuD is a small protein - 139 amino acids - which loses 24 amino acids from the arm. So it goes from 139 to 115," she said.
"We can observe this difference with electrophoresis, allowing us to determine how different conditions or other proteins might affect UmuD cleavage," said Beuning.
The team is studying different UmuD protein interactions in the lab, using biochemistry to see when and how different proteins bind to one another.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
